Evidence map›Paper›PMID 26088623›Full record

ArticleBMC infectious diseases2015

High multiple carriage and emergence of Streptococcus pneumoniae vaccine serotype variants in Malawian children.

Arox W Kamng'ona, Jason Hinds, Naor Bar-Zeev, Katherine A Gould, Chrispin Chaguza, Chisomo Msefula, Jennifer E Cornick, Benard W Kulohoma, Katherine Gray, Stephen D Bentley and 3 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Comparative pangenomics ofMicrobial genomics · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Intra-Species Interactions inFrontiers in cellular and infection microbiology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Arox W Kamng'onaMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. awkamngona@medcol.mw.
Jason HindsDivision of Clinical Sciences, St George's, University of London, London, UK. j.hinds@sgul.ac.uk.
Naor Bar-ZeevMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. naor.bar-zeev@liverpool.ac.uk.
Katherine A GouldDivision of Clinical Sciences, St George's, University of London, London, UK. kgould@sgul.ac.uk.
Chrispin ChaguzaMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. Chrispin.Chaguza@liverpool.ac.uk.
Chisomo MsefulaMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. cmsefula@medcol.mw.
Jennifer E CornickMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. J.Cornick@liverpool.ac.uk.
Benard W KulohomaMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. bkulohoma@iscb.org.
Katherine GrayBiochemistry Department, University of Malawi, College of Medicine, Blantyre, Malawi. katherinejgray@gmail.com.
Stephen D BentleyPathogen Genomics, Wellcome Trust Sanger Institute, Cambridge, UK. sdb@sanger.ac.uk.
Neil FrenchMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. N.French@liverpool.ac.uk.
Robert S HeydermanMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. r.heyderman@liverpool.ac.uk.
Dean B EverettMicrobes, Immunity and Vaccines, Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi. Dean.Everett@liverpool.ac.uk.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundCarriage of either single or multiple pneumococcal serotypes (multiple carriage) is a prerequisite for developing invasive pneumococcal disease. However, despite the reported high rates of pneumococcal carriage in Malawi, no data on carriage of multiple serotypes has been reported previously. Our study provides the first description of the prevalence of multiple pneumococcal carriage in Malawi.

methodsThe study was conducted in Blantyre and Karonga districts in Malawi, from 2008 to 2012. We recruited 116 children aged 0-13 years. These children were either HIV-infected (N = 44) or uninfected (N = 72). Nasopharyngeal samples were collected using sterile swabs. Pneumococcal serotypes in the samples were identified by microarray. Strains that could not be typed by microarray were sequenced to characterise possible genetic alterations within the capsular polysaccharide (CPS) locus.

resultsThe microarray identified 179 pneumococcal strains (from 116 subjects), encompassing 43 distinct serotypes and non-typeable (NT) strains. Forty per cent (46/116) of children carried multiple serotypes. Carriage of vaccine type (VT) strains was higher (p = 0.028) in younger (0-2 years) children (71 %, 40/56) compared to older (3-13 years) children (50 %, 30/60). Genetic variations within the CPS locus of known serotypes were observed in 19 % (34/179) of the strains identified. The variants included 13-valent pneumococcal conjugate vaccine (PCV13) serotypes 6B and 19A, and the polysaccharide vaccine serotype 20. Serotype 6B variants were the most frequently isolated (47 %, 16/34). Unlike the wild type, the CPS locus of the 6B variants contained an insertion of the licD-family phosphotransferase gene. The CPS locus of 19A- and 20-variants contained an inversion in the sugar-biosynthesis (rmlD) gene and a 717 bp deletion within the transferase (whaF) gene, respectively.

conclusionsThe high multiple carriage in Malawian children provides opportunities for genetic exchange through horizontal gene transfer. This may potentially lead to CPS locus variants and vaccine escape. Variants reported here occurred naturally, however, PCV13 introduction could exacerbate the CPS genetic variations. Further studies are therefore recommended to assess the invasive potential of these variants and establish whether PCV13 would offer cross-protection. We have shown that younger children (0-2 years) are a reservoir of VT serotypes, which makes them an ideal target for vaccination.

Indexed as

AdolescentBacterial CapsulesBacteriological TechniquesChildChild, PreschoolCross ProtectionDNA, BacterialFemaleGenetic VariationHIV InfectionsHumansInfantInfant, NewbornMalawiMaleNasopharynx13-valent pneumococcal vaccineDNA, BacterialPneumococcal Vaccines

Identifiers

PMID26088623
PMCPMC4474563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.